Clinical Trial Update: MSC for Severe aGVHD [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for mesenchymal stem cell therapy in steroid-resistant severe acute GVHD evaluating Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steroid-resistant Severe Acute Graft-versus-host Disease

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Fujian Medical University | Conditions: Steroid-resistant Severe aGVHD | Phase 2, Phase 3 | Status: UNKNOWN